Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086632
Status:
TERMINATED
Last Update Posted:
2007-12-18
First Post:
2004-07-07
Brief Title:
Study of Ovarex Oregovomab MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment
Sponsor:
Unither Pharmaceuticals
Organization:
Unither Pharmaceuticals
Organization Data
Organization:
Unither Pharmaceuticals
Class:
INDUSTRY
Study ID:
OVA-Gy-18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Unither Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None